Literature DB >> 28099389

Monitoring of vascular endothelial growth factor and its soluble receptor levels in early trauma.

Jianying Guo1, Wenwen Yan, Yong Yang, Zhiyong Wang, Fengjun Tian.   

Abstract

BACKGROUND: This clinical observation study aimed to investigate the relationship between the serum levels of vascular endothelial growth factor (VEGF) and its soluble receptors with the severity and the occurrence of late acute respiratory distress syndrome (ARDS) in early trauma.
METHODS: Sixty patients with multiple injuries were divided into three groups according to the Injury Severity Score (ISS) and the serum levels of VEGF, soluble VEGF receptor 1 (sVEGFR1), and sVEGFR2, were measured. Ten healthy people were recruited as controls. The incidence of late ARDS was also monitored, and its relationship to the above measures analyzed.
RESULTS: VEGF was not associated with ISS (p > 0.05); sVEGFR1 was positively associated with ISS (r = 0.459, p < 0.0001); however, sVEGFR2 was negatively associated with ISS (r = 0.510, p < 0.0001). The serum VEGF levels between the ARDS group and the non-ARDS group showed no significant difference (p > 0.05). sVEGFR1 in the ARDS group was significantly higher than that in the non-ARDS group (p < 0.0001), and sVEGFR2 in the ARDS group was significantly lower than that in the non-ARDS group (p < 0.0001).
CONCLUSION: In conclusion, the increasing of sVEGFR1 and the decreasing of sVEGFR2 in early trauma might be closely related to the occurrence of late ARDS. LEVEL OF EVIDENCE: Prognostic study, level III.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28099389     DOI: 10.1097/TA.0000000000001373

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  1 in total

1.  Clinical characteristics and prognosis of serous body cavity effusions in patients with sepsis: a retrospective observational study.

Authors:  Ling-Yu Xing; Jun Yin; Mian Shao; Yi-Lin Yang; Ke-Yong Li; Ming-Ming Xue; Su-Cheng Mu; Zhan Sun; Ya-Ping Zhang; Chen-Ling Yao; Xun Chu; Chao-Yang Tong; Zhen-Ju Song
Journal:  BMC Anesthesiol       Date:  2018-11-14       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.